17 studies found for:    Open Studies | "Tetanus"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Conditions: Tetanus;   Diphtheria;   Pertussis;   Whooping Cough
Interventions: Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed Formulation 1;   Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 2;   Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 3;   Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 4;   Biological: Licensed Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed;   Biological: Licensed Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
2 Recruiting Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Interventions: Biological: DTaP-IPV combination vaccine;   Biological: DTaP vaccine and IPV vaccine
3 Not yet recruiting Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Influenza Type B
Intervention:
4 Recruiting Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Conditions: Acellular Pertussis;   Tetanus;   Poliomyelitis;   Diphtheria
Interventions: Biological: Infanrix hexa;   Drug: Prevnar13
5 Recruiting Study of Sanofi Pasteur's DTaP-IPV Hep B-PRP-T Combined Vaccine in Infants Who Previously Received Hepatitis B Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Hepatitis B;   Haemophilus Influenzae Type b
Intervention: Biological: DTaP-IPV-Hep B-PRP-T combined vaccine (Hexaxim™)
6 Unknown  Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Influenzae Type B
Intervention: Biological: Shan 5
7 Not yet recruiting Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program
Condition: Healthy
Intervention: Biological: Tetanus and Diphtheria (Td) Vaccine
8 Unknown  Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed)
9 Recruiting The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses
Conditions: Rotavirus Infections;   Intestinal Bacteria Flora Disturbance;   Reaction - Vaccine Nos;   Tetanus;   Streptococcal Pneumonia
Intervention: Biological: Rotavirus vaccine, Tetanus vaccine and Pneumococcal vaccine
10 Recruiting Hepatitis B Vaccination in Infants
Conditions: Meningococcal Disease;   Pneumococcal Disease;   Haemophilus Influenzae Serotype b Disease;   Diphtheria, Tetanus and Pertussis;   Hepatitis b
Interventions: Biological: Menjugate;   Biological: Menitorix;   Biological: NeisVac-C
11 Recruiting Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women
Condition: Diphtheria-Tetanus-acellular Pertussis Vaccines
Interventions: Biological: Boostrix™;   Drug: Saline placebo
12 Recruiting TDAP Safety in Pregnant Women
Condition: Pertussis
Intervention:
13 Unknown  Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment
Condition: Colorectal Cancer
Intervention: Biological: CEA pulsed dendritic cells
14 Not yet recruiting Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
Conditions: Glioblastoma Multiforme;   Glioblastoma;   Malignant Glioma;   Astrocytoma, Grade IV;   GBM
Interventions: Biological: pp65 DC with GM-CSF;   Biological: Influenza DC with GM-CSF;   Biological: PBMC with GM-CSF;   Drug: Td;   Drug: Saline
15 Recruiting DC Migration Study for Newly-Diagnosed GBM
Conditions: Glioblastoma;   Astrocytoma, Grade IV;   Giant Cell Glioblastoma;   Glioblastoma Multiforme
Interventions: Biological: Group I unpulsed DCs;   Biological: Group II Td;   Biological: Human CMV pp65-LAMP mRNA-pulsed autologous DCs;   Biological: 111In-labeled DCs;   Drug: Temozolomide;   Drug: Saline;   Drug: Group III basiliximab and Td
16 Unknown  Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])
Condition: Malaria
Interventions: Biological: Malaria vaccine AMA1 (PfAMA-1-FVO[25-545];   Biological: AMA1
17 Recruiting Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.
Condition: Relapsing Forms of Multiple Sclerosis
Interventions: Drug: dimethyl fumarate;   Biological: tetanus diphtheria toxoids vaccine;   Biological: 23-valent pneumococcal polysaccharide vaccine;   Biological: meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent);   Drug: non-pegylated interferon

Indicates status has not been verified in more than two years